Literature DB >> 29512011

Ecotoxicological impacts of surface water and wastewater from conventional and advanced treatment technologies on brood size, larval length, and cytochrome P450 (35A3) expression in Caenorhabditis elegans.

Aennes Abbas1, Lucie Valek2, Ilona Schneider3, Anna Bollmann4, Gregor Knopp5, Wolfram Seitz4, Ulrike Schulte-Oehlmann3, Jörg Oehlmann3, Martin Wagner3,6.   

Abstract

Anthropogenic micropollutants and transformation products (TPs) negatively affect aquatic ecosystems and water resources. Wastewater treatment plants (WWTP) represent major point sources for (micro)pollutants and TPs in urban water cycles. The aim of the current study was to assess the removal of micropollutants and toxicity during conventional and advanced wastewater treatment. Using wild-type and transgenic Caenorhabditis elegans, the endpoint reproduction, growth, and cytochrome P450 (CYP) 35A3 induction (via cyp-35A3::GFP) were assessed. Samples were collected at four WWTPs and a receiving surface water. One WWTP included the advanced treatments: ozonation followed by granular activated carbon (GAC) or biological filtration (BF), respectively. Relevant micropollutants and WWTP parameters (n = 111) were included. Significant reproductive toxicity was detected for one WWTP effluent (31-83% reduced brood size). Three of four effluents significantly promoted the growth of C. elegans larvae (49-55% increased lengths). This effect was also observed for the GAC (34-41%) and BF (30%) post-treatments. Markedly, significant cyp-35A3::GFP induction was detected for one effluent before and after ozonation, being more pronounced for the ozonated samples (5- and 7.4-fold above controls). While the advanced treatments decreased the concentrations of most micropollutants, the observed effects may be attributed to effects of residual target compounds and/or compounds not included in the target chemical analysis. This highlights the need for an integrated assessment of (advanced) wastewater treatment covering both biological and chemical parameters.

Entities:  

Keywords:  CYP biomarker; Contaminants of emerging concern; In vivo bioassay; Municipal effluents; Ozonation; Persistent organic pollutants (POPs); Toxic effects; Transformation products

Mesh:

Substances:

Year:  2018        PMID: 29512011     DOI: 10.1007/s11356-018-1605-2

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  43 in total

1.  Assessing the ecotoxicity of pesticide transformation products.

Authors:  Chris J Sinclair; Alistair B A Boxall
Journal:  Environ Sci Technol       Date:  2003-10-15       Impact factor: 9.028

2.  A systematic gene expression screen of Caenorhabditis elegans cytochrome P450 genes reveals CYP35 as strongly xenobiotic inducible.

Authors:  R Menzel; T Bogaert; R Achazi
Journal:  Arch Biochem Biophys       Date:  2001-11-15       Impact factor: 4.013

3.  Caenorhabditis elegans generates biologically relevant levels of genotoxic metabolites from aflatoxin B1 but not benzo[a]pyrene in vivo.

Authors:  Maxwell C K Leung; Jared V Goldstone; Windy A Boyd; Jonathan H Freedman; Joel N Meyer
Journal:  Toxicol Sci       Date:  2010-09-23       Impact factor: 4.849

4.  A high-throughput method for assessing chemical toxicity using a Caenorhabditis elegans reproduction assay.

Authors:  Windy A Boyd; Sandra J McBride; Julie R Rice; Daniel W Snyder; Jonathan H Freedman
Journal:  Toxicol Appl Pharmacol       Date:  2010-03-04       Impact factor: 4.219

5.  A survey on trace organic chemicals in a German water protection area and the proposal of relevant indicators for anthropogenic influences.

Authors:  Wolfram Seitz; Rudi Winzenbacher
Journal:  Environ Monit Assess       Date:  2017-05-01       Impact factor: 2.513

6.  Cytochrome P450s and short-chain dehydrogenases mediate the toxicogenomic response of PCB52 in the nematode Caenorhabditis elegans.

Authors:  Ralph Menzel; Hui Ling Yeo; Stefanie Rienau; Shuang Li; Christian E W Steinberg; Stephen R Stürzenbaum
Journal:  J Mol Biol       Date:  2007-05-04       Impact factor: 5.469

7.  In vivo identification of genes that modify ether-a-go-go-related gene activity in Caenorhabditis elegans may also affect human cardiac arrhythmia.

Authors:  Christina I Petersen; Toni R McFarland; Svetlana Z Stepanovic; Ping Yang; David J Reiner; Kenshi Hayashi; Alfred L George; Dan M Roden; James H Thomas; Jeffrey R Balser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

8.  Environmental Exposure of Aquatic and Terrestrial Biota to Triclosan and Triclocarban.

Authors:  Talia E Chalew; Rolf U Halden
Journal:  J Am Water Works Assoc       Date:  2009

9.  The non-target organism Caenorhabditis elegans withstands the impact of sulfamethoxazole.

Authors:  Shuyan Liu; Nadine Saul; Bo Pan; Ralph Menzel; Christian E W Steinberg
Journal:  Chemosphere       Date:  2013-09-12       Impact factor: 7.086

10.  Use of transgenic GFP reporter strains of the nematode Caenorhabditis elegans to investigate the patterns of stress responses induced by pesticides and by organic extracts from agricultural soils.

Authors:  Charumathi Anbalagan; Ivan Lafayette; Melissa Antoniou-Kourounioti; Carmen Gutierrez; Jose Rodriguez Martin; Debapratim K Chowdhuri; David I De Pomerai
Journal:  Ecotoxicology       Date:  2012-10-19       Impact factor: 2.823

View more
  2 in total

1.  Zebrafish CYP1A expression in transgenic Caenorhabditis elegans protects from exposures to benzo[a]pyrene and a complex polycyclic aromatic hydrocarbon mixture.

Authors:  Jamie B Harris; Jessica H Hartman; Anthony L Luz; Joanna Y Wilson; Audrey Dinyari; Joel N Meyer
Journal:  Toxicology       Date:  2020-05-01       Impact factor: 4.221

2.  Planococcus maritimus ML1206 Isolated from Wild Oysters Enhances the Survival of Caenorhabditis elegans against Vibrio anguillarum.

Authors:  Ying-Xiu Li; Nan-Nan Wang; Yan-Xia Zhou; Chun-Guo Lin; Jing-Shan Wu; Xin-Qi Chen; Guan-Jun Chen; Zong-Jun Du
Journal:  Mar Drugs       Date:  2021-03-12       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.